{"id":"https://openalex.org/W2249379784","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.4121","title":"Phase I study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC).","display_name":"Phase I study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC).","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2249379784","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.4121","mag":"2249379784"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.4121","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.4121","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.4121","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021465650","display_name":"Matteo Simonelli","orcid":"https://orcid.org/0000-0002-5264-1251","observed_orcids":["https://orcid.org/0000-0002-5264-1251"]},"institutions":[{"id":"https://openalex.org/I1339471597","display_name":"Humanitas University","ror":"https://ror.org/020dggs04","country_code":"IT","type":"education","lineage":["https://openalex.org/I1339471597"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Matteo Simonelli","raw_affiliation_strings":["Humanitas Cancer Center, Rozzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Cancer Center, Rozzano, Italy","institution_ids":["https://openalex.org/I1339471597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062532607","display_name":"Paolo Andrea Zucali","orcid":"https://orcid.org/0000-0002-2274-1702","observed_orcids":["https://orcid.org/0000-0002-2274-1702"]},"institutions":[{"id":"https://openalex.org/I1339471597","display_name":"Humanitas University","ror":"https://ror.org/020dggs04","country_code":"IT","type":"education","lineage":["https://openalex.org/I1339471597"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo A. Zucali","raw_affiliation_strings":["Humanitas Cancer Center, Rozzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Cancer Center, Rozzano, Italy","institution_ids":["https://openalex.org/I1339471597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084427458","display_name":"Melanie B. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melanie B. Thomas","raw_affiliation_strings":["Medical University of South Carolina, Charleston, SC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of South Carolina, Charleston, SC","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056125807","display_name":"Alan Brisendine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095449","display_name":"MUSC Hollings Cancer Center","ror":"https://ror.org/00w52vt71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Brisendine","raw_affiliation_strings":["Medical University of South Carolina Hollings Cancer Center, Charleston, SC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of South Carolina Hollings Cancer Center, Charleston, SC","institution_ids":["https://openalex.org/I4210095449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039492614","display_name":"Jordan D. Berlin","orcid":"https://orcid.org/0000-0001-7571-2385","observed_orcids":["https://orcid.org/0000-0001-7571-2385"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jordan Berlin","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034667041","display_name":"Cristina Noberasco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cristina Noberasco","raw_affiliation_strings":["European Institute of Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Institute of Oncology, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005375804","display_name":"Crystal Shereen Denlinger","orcid":"https://orcid.org/0000-0002-5663-7751","observed_orcids":["https://orcid.org/0000-0002-5663-7751"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Crystal Shereen Denlinger","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045534","display_name":"Tae\u2010You Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Tae-You Kim","raw_affiliation_strings":["Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100766578","display_name":"Armando Santoro","orcid":"https://orcid.org/0000-0003-1709-9492","observed_orcids":["https://orcid.org/0000-0003-1709-9492"]},"institutions":[{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Armando Santoro","raw_affiliation_strings":["Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033398414","display_name":"Corrado Gallo\u2010Stampino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corrado Gallo-Stampino","raw_affiliation_strings":["Pfizer Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Oncology, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020937314","display_name":"Marina Carpentieri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142120","display_name":"Pfizer (Italy)","ror":"https://ror.org/03htt2d69","country_code":"IT","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210142120"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marina Carpentieri","raw_affiliation_strings":["Pfizer Inc., Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Milan, Italy","institution_ids":["https://openalex.org/I4210142120"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Erjian Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erjian Wang","raw_affiliation_strings":["Pfizer Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., San Diego, CA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"James Andrew Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Andrew Williams","raw_affiliation_strings":["Pfizer Oncology, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Oncology, La Jolla, CA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009935310","display_name":"Filippo de Braud","orcid":"https://orcid.org/0000-0003-0103-730X","observed_orcids":["https://orcid.org/0000-0003-0103-730X"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo G. De Braud","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"4121","last_page":"4121"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/alk1","display_name":"ALK1","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tgf-beta-receptor","display_name":"TGF-beta receptor","score":0.8230000138282776},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/sorafenib-refractory-disease","display_name":"sorafenib-refractory disease","score":0.9110000133514404},{"id":"https://openalex.org/keywords/telangiectasia","display_name":"telangiectasia","score":0.8080000281333923},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.40799999237060547},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9449999928474426},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.49799999594688416},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.4230000078678131}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9336947798728943},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8676224946975708},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7090541124343872},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6441428661346436},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5681233406066895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5398908853530884},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5159812569618225},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4347279667854309},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41818079352378845},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4060748815536499},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38484352827072144},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.24879556894302368}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.4121","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.4121","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.4121","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8299999833106995,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2908236993","https://openalex.org/W2462071496","https://openalex.org/W2340207507","https://openalex.org/W4245464536","https://openalex.org/W2162766001","https://openalex.org/W2597590768","https://openalex.org/W2242531592","https://openalex.org/W2247505779","https://openalex.org/W3125157824","https://openalex.org/W4376455855"],"abstract_inverted_index":{"4121":[0],"Background:":[1],"PF-03446962,":[2],"a":[3,13,21,31,341],"fully":[4,50],"human":[5],"IgG2":[6],"mAb":[7,345],"against":[8],"ALK-1":[9,45,61,116],"(Activin-Receptor":[10],"Like":[11],"Kinase-1,":[12],"specific":[14],"TGF-\u03b2":[15],"receptor)":[16],"with":[17,38,121,162,168,171,223,303,330],"anti-angiogenesis":[18],"activity,":[19],"showed":[20],"favourable":[22],"safety":[23,77],"profile":[24,231],"and":[25,46,78,107,117,129,148,157,181,197,208,234,249,254,279,292],"early":[26],"signs":[27],"of":[28,69,113,225,325],"efficacy":[29,331],"in":[30,35,56,85,195,200,206,211,319,343,352],"dose":[32,227],"escalation":[33,228],"study":[34],"patients":[36],"(pts)":[37],"solid":[39],"tumors.":[40],"While":[41],"the":[42,52,218,226,320,336],"interplay":[43],"between":[44],"VEGF-A":[47],"is":[48,340],"not":[49],"elucidated,":[51],"clinical":[53,349],"benefit":[54],"observed":[55,266,351],"VEGF-TKI":[57],"pre-treated":[58,165],"pts":[59,87,99,161],"supports":[60],"acting":[62],"as":[63],"an":[64,82,260,316],"escape":[65],"mechanism":[66],"after":[67,90],"failure":[68],"VEGF":[70],"blockade.":[71],"Herein":[72],"we":[73],"report":[74],"preliminary":[75],"efficacy,":[76],"PK":[79,156,215],"results":[80],"from":[81,217],"expansion":[83,355],"cohort":[84,220,356],"HCC":[86,98,164,219,354],"who":[88],"progressed":[89,100],"receiving":[91],"at":[92,145,166,335],"minimum":[93,167],"sorafenib.":[94,103],"Methods:":[95],"Child-Pugh":[96,203],"A":[97],"on/intolerant":[101],"to":[102],"Tumor":[104,136],"specimens":[105],"(diagnostic":[106],"pre-PF-03446962)":[108],"collected":[109],"for":[110,306],"IHC":[111],"assessment":[112],"CD31,":[114],"TGF-\u03b2,":[115],"cMET.":[118],"Pts":[119],"treated":[120],"7":[122,298],"mg/kg":[123],"PF-03446962":[124,300,339],"on":[125],"Day":[126],"1,":[127],"29":[128],"then":[130],"q2":[131],"wks.":[132],"Efficacy":[133],"endpoints:":[134],"Objective":[135],"Response":[137],"(OR)":[138],"by":[139,237,246],"RECIST,":[140],"Disease":[141],"Control":[142],"Rate":[143],"(DCR)":[144],"12":[146,308],"wks,":[147],"Time":[149],"To":[150],"Progression":[151],"(TTP).":[152],"Secondary":[153],"objectives:":[154],"safety,":[155],"PD.":[158],"Results:":[159],"24":[160],"advanced":[163],"sorafenib":[169],"(12/24":[170],"\u2265":[172,307],"2":[173],"prior":[174],"therapies)":[175],"have":[176],"been":[177],"enrolled;":[178],"19":[179],"males":[180],"5":[182],"females":[183],"(median":[184],"age:":[185],"64":[186],"y).":[187],"Pts\u2019":[188],"characteristics":[189],"were:":[190],"ECOG":[191],"PS":[192],"=":[193,198,204,209],"0":[194],"10":[196],"1":[199],"14":[201],"pts;":[202],"A5":[205],"16":[207],"A6":[210],"8":[212],"pts.":[213],"The":[214],"profiles":[216],"were":[221,244,271,287],"consistent":[222],"those":[224],"cohorts.":[229],"Safety":[230],"was":[232,264,290,294,301],"manageable":[233],"mainly":[235],"characterized":[236],"Gr":[238,241,268],"1-2":[239],"events.":[240],"3-4":[242],"events":[243],"represented":[245],"thrombocytopenia":[247],"(12.5%)":[248],"lipase":[250],"increase,":[251],"AST":[252],"increase":[253],"abdominal":[255,281],"pain":[256],"(4.2%":[257],"each).":[258],"Telangiectasia,":[259],"anti-ALK-1":[261,312],"mediated":[262],"toxicity,":[263],"also":[265],"(8.3%,":[267],"1).":[269],"There":[270],"3":[272],"treatment-related":[273],"serious":[274],"AEs":[275],"(one":[276],"tumor":[277,327],"necrosis":[278],"two":[280],"pain).":[282],"No":[283],"CRs":[284],"or":[285],"PRs":[286],"reported;":[288],"DCR":[289],"29.2%":[291],"mTTP":[293],"3.0":[295],"months.":[296],"In":[297],"pts,":[299],"associated":[302],"stable":[304],"disease":[305],"weeks,":[309],"suggesting":[310],"that":[311],"treatment":[313],"may":[314],"be":[315,333],"effective":[317],"strategy":[318],"post-VEGFi":[321],"setting.":[322],"Correlation":[323],"data":[324],"target":[326],"protein":[328],"expression":[329],"will":[332],"presented":[334],"Conference.":[337],"Conclusions:":[338],"first":[342],"class":[344],"anti":[346],"ALK-1.":[347],"Preliminary":[348],"activity":[350],"this":[353],"warrants":[357],"further":[358],"investigations.":[359],"Clinical":[360],"trial":[361],"information:":[362],"NCT00557856.":[363]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}